These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17565424)

  • 1. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
    Merzlyakov M; Chen L; Hristova K
    J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
    Sarabipour S; Del Piccolo N; Hristova K
    Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
    Li E; You M; Hristova K
    J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
    Li E; You M; Hristova K
    Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
    Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET.
    Placone J; Hristova K
    PLoS One; 2012; 7(10):e46678. PubMed ID: 23056398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
    Sarabipour S; Hristova K
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.
    You M; Li E; Hristova K
    Biochemistry; 2006 May; 45(17):5551-6. PubMed ID: 16634636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and initial characterization of FGFR3 transmembrane domain: consequences of sequence modifications.
    Iwamoto T; You M; Li E; Spangler J; Tomich JM; Hristova K
    Biochim Biophys Acta; 2005 Mar; 1668(2):240-7. PubMed ID: 15737335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
    He L; Shobnam N; Hristova K
    Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization.
    Chen L; Placone J; Novicky L; Hristova K
    Sci Signal; 2010 Nov; 3(150):ra86. PubMed ID: 21119106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple "proximity" correction for Förster resonance energy transfer efficiency determination in membranes using lifetime measurements.
    Posokhov YO; Merzlyakov M; Hristova K; Ladokhin AS
    Anal Biochem; 2008 Sep; 380(1):134-6. PubMed ID: 18559252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane helix heterodimerization in lipid bilayers: probing the energetics behind autosomal dominant growth disorders.
    Merzlyakov M; You M; Li E; Hristova K
    J Mol Biol; 2006 Apr; 358(1):1-7. PubMed ID: 16500676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3.
    Volynsky PE; Polyansky AA; Fakhrutdinova GN; Bocharov EV; Efremov RG
    J Am Chem Soc; 2013 Jun; 135(22):8105-8. PubMed ID: 23679838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.
    Del Piccolo N; Sarabipour S; Hristova K
    J Biol Chem; 2017 Jan; 292(4):1288-1301. PubMed ID: 27927983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forster resonance energy transfer measurements of transmembrane helix dimerization energetics.
    Merzlyakov M; Hristova K
    Methods Enzymol; 2008; 450():107-27. PubMed ID: 19152858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.
    Li E; Hristova K
    Cell Adh Migr; 2010; 4(2):249-54. PubMed ID: 20168077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers.
    You M; Spangler J; Li E; Han X; Ghosh P; Hristova K
    Biochemistry; 2007 Oct; 46(39):11039-46. PubMed ID: 17845056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain.
    Sarabipour S; Hristova K
    Biophys J; 2013 Jul; 105(1):165-71. PubMed ID: 23823235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
    Li E; Hristova K
    Biochemistry; 2006 May; 45(20):6241-51. PubMed ID: 16700535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.